To allow designers to develop device-simulation models earlier in the design cycle for faster overall IC design, Santa Clara, Calif.-based Agilent Technologies Inc today rolled out what it believes is ...
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, has launched its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results